- Barrons.com•7 days ago
No longer must Chinese parents stop their procreation at one child, and that should help U.S.-based Mead Johnson Nutrition (MJN) sell more infant formula. There is competition among formula sellers including France's Danone (DANOY), whose known brands are valued and can command premium prices in China after tampering and other health scares. But BMO Capital Markets Analyst Amit Sharma writes that "most investors do not expect the removal of one-child restrictions to have a meaningful impact on China's birth rates and on Mead Johnson's operating performance -- "at least in a reasonable investable time frame." BMO's Sharma disagrees. Sharma writes: " ... The expected 6%-11% annual increase in live births between 2017 and 2022 (vs. +0.5% in the last ten years) should lead to mid-single-digits incremental volume growth in the Chinese formula category (vs. low-single digits in the last five years).
- Moody's•14 days agoDanone -- Moody's: Bottled water to help Europe's food and beverage firms offset declining growth in other sectors
Milan, September 14, 2016-- Fast-growing demand for bottled water will continue over the next five years as health-conscious consumers shun sugary drinks like traditional carbonated soft drinks and fruit ...
Other OTC - Other OTC Delayed Price. Currency in USD
|Day's Range||0.00 - 0.00|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||23.47|
|Avg Vol (3m)||1,161,009|
|Dividend & Yield||0.36 (2.47%)|